ISRCTN ISRCTN17692172
DOI https://doi.org/10.1186/ISRCTN17692172
ClinicalTrials.gov (NCT) NCT03136718
Protocol serial number 33776
Sponsor Nottingham University Hospitals NHS Trust
Funder National Institute for Health Research
Submission date
15/01/2018
Registration date
23/01/2018
Last edited
20/06/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Ear, Nose and Throat
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
People with hearing loss struggle to hold conversations with others. This can be socially isolating and lowers quality of life. Hearing aids help overcome hearing loss. However, many people know little about them. Hearing aids can be difficult to use and do not give perfect hearing. Many hearing aids are therefore abandoned or underused. In the past, we have worked with hearing aid users to produce multimedia, interactive educational videos about how best to use hearing aids and to communicate well. We have shown that these videos improve patient’s knowledge of hearing aids and communication. They have also increased hearing aid use and improved patient’s confidence. Educational videos can be improved by tailoring them to the needs of each person. They can also be more easily accessed by running them on the internet. Mobile devices, such as smartphones and tablet computers, provide an ideal means to achieve this. This research aims to work with hearing aid users to adapt our existing educational videos for use with people’s own mobile devices. Informed by the views of first-time hearing aid users, we plan to develop a larger study. This is to see whether our new educational videos, delivered through mobile devices, really make a difference to the lives of those affected by hearing loss. If they do, we plan to find out how and why. The overall study goal is to improve hearing aid use by helping hearing aid users to self-manage their condition.

Who can participate?
Adults aged 18 and older who are first-time hearing aid users.

What does the study involve?
Participants are asked to try out educational videos on their own devices. After 10-12 weeks participants are asked questions about how they got on with them, what worked and what made a difference to them.

What are the possible benefits and risks of participating?
There are no direct benefits or risks with participating.

Where is the study run from?
1. Nottingham Biomedical Research Centre (BRC) (UK)
2. Nottingham Audiology Adult Services (UK)

When is the study starting and how long is it expected to run for?
February 2018 to September 2018

Who is funding the study?
National Institute for Health Research (UK)

Who is the main contact?
Dr Melanie Ferguson
melanie.ferguson@nottingham.ac.uk

Contact information

Dr Melanie Ferguson
Scientific

National Institute for Health Research Nottingham Biomedical Research Centre
Ropewalk House
113 The Ropewalk
Nottingham
NG1 5DU
United Kingdom

ORCiD logoORCID ID 0000-0002-8096-869X
Phone +44 115 823 2600
Email melanie.ferguson@nottingham.ac.uk

Study information

Primary study designInterventional
Study design; Both; Design type: Prevention, Psychological & Behavioural, Rehabilitation, Qualitative
Secondary study designNon randomised study
Participant information sheet ISRCTN17692172_PIS_V3_22Mar17.pdf
Scientific titleThe development and feasibility of m-health technologies to improve hearing aid use and benefit in first-time hearing aid users
Study objectivesThe aim of this study will establish the feasibility of a theoretically-driven, personalised educational intervention delivered through mobile technologies in first-time hearing aid users.
Ethics approval(s)East of England – Cambridgeshire and Hertfordshire Research Ethics Committee, 28/03/2017, ref: 17/EE/0117
Health condition(s) or problem(s) studiedSpecialty: Ear, nose and throat, Primary sub-specialty: Ear, nose and throat; UKCRC code/ Disease: Ear/ Diseases of middle ear and mastoid
InterventionA theoretically-driven, personalised educational intervention delivered through mobile technologies based on the C2Hear (https://www.youtube.com/C2HearOnline) multimedia videos, or Reusable Learning Objects (RLOs). The intervention will include shorter 'bite-sized' RLOs suitable for mobile technologies (or mRLOs), which will also enable individualised learning.

Participants are asked to try out the videos on the their own devices. After 10-12 weeks participants speak to each user individually. Participants are asked questions about how they got on with them, what worked and what made a difference to them.
Intervention typeOther
Primary outcome measure(s)

Hearing aid use is measured using datalogging (i.e. use in hours per day internal to the hearing aid) following 10-12 weeks of independent use of the mRLO intervention.

Key secondary outcome measure(s)

1. Self-reported hearing-related handicap and disability is measured using the Glasgow Hearing Aid Benefit Profile (GHABP) Part I at baseline
2. Self-reported hearing aid use, benefit, satisfaction and residual disability is measured using the GHABP Part II following 10-12 weeks of independent use of the mRLO intervention
3. Hearing-specific quality of life is measured using the Hearing Handicap Inventory for the Elderly (HHIE) at baseline and immediately post-intervention
4. Hearing aid self-efficacy is measured using the Measure of Audiologic Rehabilitation Self-efficacy for Hearing Aids (MARS-HA) at baseline and following 10-12 weeks of independent use of the mRLO intervention
5. Social behaviours and perceptions are measured using the Social Participation Restrictions Questionnaire (SPaRQ) at baseline and following 10-12 weeks of independent use of the mRLO intervention
6. Hearing aid knowledge is measured using the Hearing Aid and Communication Knowledge (HACK) questionnaire at baseline and following 10-12 weeks of independent use of the mRLO intervention
7. Working memory is measured using the Wechsler Adult Intelligence Scale Digit Span task at baseline and following 10-12 weeks of independent use of the mRLO intervention
8. Change in hearing difficulty is measured using the Clinical Global Impression scale following 10-12 weeks of independent use of the mRLO intervention
9. Participants will be asked if they experienced any adverse effects arising from the intervention 10-12 weeks of independent use of the mRLO intervention

Completion date30/09/2018

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration77
Key inclusion criteria1. Adults aged ≥18 years (no upper age limit)
2. First-time hearing aid users (or if previous users, but not having worn hearing aids for more than 3 years)
3. English as first spoken language or good understanding of English. It is important that participants can understand the content of the resources and work with the interactive elements, as well as be able to answer outcome questionnaires, to ensure valid data are collected.
4. Familiar with mobile technologies (e.g. owns a smartphone or tablet device, or uses one regularly)
Key exclusion criteriaUnable to complete the questionnaires without assistance due to age-related problems (e.g. cognitive decline or dementia), to ensure valid data are collected.
Date of first enrolment05/02/2018
Date of final enrolment30/06/2018

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centres

National Institute for Health Research (NIHR)
Nottingham Biomedical Research Centre (BRC)
Ropewalk House
113 The Ropewalk
Nottingham
NG1 5DU
United Kingdom
Nottingham Audiology Adult Services
Nottingham University Hospitals NHS Trust
Ropewalk House
113 The Ropewalk
Nottingham
NG1 5DU
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryOther
IPD sharing planThe datasets generated and/or analysed during the current study during this study will be included in the subsequent results publication.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
HRA research summary 28/06/2023 No No
Interim results article qualitative results 05/08/2020 20/06/2022 Yes No
Participant information sheet version V3 22/03/2017 23/01/2018 No Yes
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Additional files

ISRCTN17692172_PIS_V3_22Mar17.pdf
Uploaded 23/01/2018

Editorial Notes

20/06/2022: Publication reference added.
10/01/2020: ClinicalTrials.gov number added.
26/01/2018: Internal review